Opioid peptides do not modulate atrial natriuretic peptide or aldosterone release under basal conditions in man.

Journal article

The effect of two analogues of [Met]-enkephalin, [D-Ala2,N-Phe4,Met(0)-ol5]-enkephalin and its guanyl derivative, on plasma concentrations of atrial natriuretic peptide (ANP) and serum aldosterone in six normal subjects was investigated. All subjects were given a 1 litre water load to inhibit vasopressin release. Both analogues, when injected i.v. at a dose of 100 micrograms, stimulated release of prolactin and GH and inhibited serum cortisol; there was no significant change in blood pressure, pulse rate or urine output. Neither plasma concentrations of ANP nor serum aldosterone levels changed significantly after injection of either analogue at a low or high dose. Naloxone, given i.v. as an 8 mg bolus, also failed to alter concentrations of either ANP or aldosterone, while it significantly stimulated the release of serum LH and cortisol. It was concluded that under basal conditions opiate receptors are unable to modulate plasma ANP or serum aldosterone concentrations.

Authors: Borges, F; Anderson, J; Volta, C; Perry, L; Drury, P

• Publication status: Published
• Journal: Journal of endocrinology
• Volume: 116
• Issue: 2
• Pages: 313-317
• Publication date: 1988-02-01
• DOI: 10.1677/joe.0.1160313
• EISSN: 1479-6805
• ISSN: 0022-0795
• Language: English
• Keywords: Prolactin; Aldosterone; Guanine; Growth Hormone; Atrial Natriuretic Factor; Hydrocortisone; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Male; Adult; Naloxone; Humans